Giuseppe Curigliano, MD, PhD is Chair of the Division of Experimental Therapeutics at European Institute of Oncology, Milan, Italy, where besides his clinical work. He is a clinician and researcher specializing in breast cancer.
Dr. Curigliano earned his MD at the University of Cattolica, in Rome, Italy. He also holds a PhD in clinical pharmacology from the University of Pisa. He completed his postdoctoral fellowship in South Carolina Medical School, Charleston (1993-1994) working on clinical immunology. He moved to the Comprehensive Cancer Center at Columbia University in New York, USA (1995-96), working on molecular epidemiology studies related to carcinogen-DNA adducts interactions.
He moved to the European Institute of Oncology in 1999. He is an active member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR) and the European Society of Medical Oncology (ESMO).
He is founding member of/and current president of the International Cardio-Oncology Society (ICOS). He serves as faculty member in the European School of Oncology (ESO). He is member of the Scientific Advisory Committee of the International Breast Cancer Study Group (IBCSG). He served on the Program Scientific Committee of ESMO 2012 and 2013. He served on the Program Scientific Committee of the St Gallen conference 2009, 2011, 2013 and 2015.
He served as a Susan G. Komen for the Cure Scholar. He served on the Program Scientific and Executive Committees of the IMPAKT Breast Cancer Conference 2011, 2012, 2013. He served as Chair of the metastatic breast cancer track for ESMO 2014 meeting in Madrid.
He served as Scientific Chair for the IMPAKT 2014 meeting in Brussels. He is member of the Editorial Board of Journal of Clinical Oncology and Annals of Oncology. He serves in the press committee of the European Society of Medical Oncology as Spokesperson coordinator for breast cancer.
